Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neoplasm Metastasis × Radiosurgery × Clear all

Phase

Phase NA 20 Phase 2 20 Phase 3 13 Phase 1 10 Phase 1/2 7 Phase EARLY_PHASE1 2 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Head and Neck Neoplasms 1 Glioblastoma 1

Interventions

Zoledronic Acid 3 Bevacizumab 3 exemestane 2 Therapeutics 2 Oxaliplatin 2 Misoprostol 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Ibandronic Acid 2 Fluorouracil 2 Cetuximab 2 Capecitabine 2 vandetanib 1 palbociclib 1 liposomal doxorubicin 1 huaier 1 eribulin 1 enzalutamide 1 darolutamide 1 cabozantinib 1 aldesleukin 1 Vindesine 1 Trastuzumab 1 Sugars 1 Stents 1 Standard of Care 1 Sorafenib 1 Radiosurgery 1 Platinum 1 Pharmaceutical Preparations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05900908 2025-04-10

PATHWAyS

GT Medical Technologies, Inc.

Phase 4 Withdrawn

Glioblastoma, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡